A Japanese health ministry proposal to impose steeper price cuts on certain medicines deemed to carry poor cost-effectiveness profiles cleared…
HOME > REGULATORY
REGULATORY
- Sakigake-Designated HAE Med Berotralstat, AZ’s Acalabrutinib Clear PAFSC Review
November 2, 2020
- MHLW to Introduce Vaccination Facilitation System for Wholesalers, Medical Institutions
November 2, 2020
- OxyContin Gets Delayed Approval in Japan with Special Distribution Scheme Now in Place
October 30, 2020
- MHLW’s Switch OTC Panel to Take on Mere Advisory Role in Line with Govt’s Policy
October 30, 2020
- Forxiga’s Heart Failure Use Now in Line for November Approval, Covers HFrEF Patients
October 30, 2020
- Japan to Receive 50 Million Doses of Moderna COVID-19 Vaccines via Takeda
October 29, 2020
- Chuikyo Reps Agree on Need to Validate Current Cost-Effectiveness Analysis Scheme
October 29, 2020
- Pharmaceutical Development Council Holds 1st Meeting; Aiming to Sort Out Priority Issues by March
October 29, 2020
- Bill to Amend Immunization Act Submitted to Diet
October 28, 2020
- MHLW Issues Notification on Establishing COVID-19 Vaccination Systems
October 28, 2020
- PM Suga Vows to Work towards Annual Price Revisions: Diet Policy Speech
October 27, 2020
- Reform Minister Asks MHLW to Facilitate Global Launch of Japan-Originated Medical Software Programs
October 27, 2020
- 1st Working Group Meeting for Prioritization of “Stable Supply Medicines” Set for Early November
October 26, 2020
- MHLW Continues to Collect Info on WHO-Led Study on Veklury
October 26, 2020
- MHLW Wants Distribution Improvement Confab by Year-End, Reckless Discounts Seen with Pricey Meds
October 22, 2020
- Xenograft Library Derived from Japanese Cancer Patients Now Up and Running
October 22, 2020
- No Skipping of Japanese Translation for COVID-19 Vaccine Dossiers: PMDA Official
October 21, 2020
- PMDA Sees Studies on Preventive Effect as a “Must” for Coronavirus Vaccines: Official
October 21, 2020
- Keidanren Calls for Clearer Classification Criteria for “Software as a Medical Device” to Promote Development
October 21, 2020
- Vice Health Minister Vows to Work on Law Amendment to Set Up Sound Vaccination Scheme
October 20, 2020
ページ
A Japanese drug pricing panel on November 11 discussed ways to respond to the US most-favored-nation (MFN) policy, with healthcare…
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…